Promoting Education and
   Research in Clinical and Translational
Science across the Career Pipeline

PhD in Clinical and Translational Science

Home > PhD in Clinical and Translational Science > Our Students > Student Information

Sarah Taylor, MD


Assistant Professor of Gynecologic Oncology, Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine


BA, Bryn Mawr College, 2002
MD, West Virginia University School of Medicine, 2008

Research Interest  
Targeted and novel treatments of gynecologic cancer
Correlated biomarker development for defining personalized cancer therapy
Screening and early detection of gynecologic cancers

Sarah is an Assistant Professor of Gynecologic Oncology and a student in the PhD program and Clinical and Translational Science. Sarah is interested in gynecologic malignancies with research emphasis on ovarian cancer. Her professional goal is to become an early phase clinical trialist in addition to the clinical work that she already does as a gynecologic oncologist. As a clinical trialist, Sarah wishes to utilize her research and collaborations with translational scientist to bring new treatment, screening and early detection methods into first in human trials.
Recent Grants
Title: Molecular Signature in Defining Endometrial Cancer Subtypes
Role: Principle Investigator
Funding Agency: Magee-Women’s Foundation
Start Year: 2016
End Year: 2017
Title: Identifying targetable pathways in molecular analysis of uterine leiomyosarcoma
Role: Principle Investigator
Funding Agency: Magee-Women’s Foundation
Start Year: 2015
End Year: 2016

Recent Peer-Reviewed Publications
Taylor SE, Li R, Petschauer JS, Donovan H, O'Neal S, Keeler AW, Zamboni WC, Edwards RP, Zorn KK. Phase I study of intravenous (IV) docetaxel and intraperitoneal (IP) oxaliplatin in recurrent ovarian and fallopian tube cancer. Gynecol Oncol. 2015; Jun 23. pii: S0090-8258(15)30047-0. doi: 10.1016/j.ygyno.2015.06.026.
Taylor SE, Beck T, Krivak T, Zorn KK, Kelley J, Edwards RP. Successful Oxaliplatin Salvage for Recurrent Ovarian Cancer after Carboplatin/Cisplatin Hypersensitivity Reaction. J Gynecol Oncol. 2014; Jul;134(1): 68-72.
O'Brien CP, Taylor SE, O'Leary JJ, Finn SP. Molecular testing in oncology: Problems, pitfalls and progress. Lung Cancer. 2014; Mar; 83(3): 309-315.
Taylor SE, Smith AL, Krivak TC, Rungruang B. Treatment Patterns and Outcomes in Pregnancy-Associated Adenocarcinoma of the Cervix. Gynecol Surg. 2014; 30(1): 5-11.
Luiza JW, Taylor SE, Gao FF, Edwards RP. Placental site trophoblastic tumor: Immunohistochemistry algorithm key to diagnosis and review of literature. Gynecol Oncol Case Rep. 2013; Nov 21;7: 13-5.
Taylor S, McBee W, Richard S, Edwards R. Radical Hysterectomy for Early Stage Cervical Cancer: Laparoscopy versus Laparotomy. JSLS. 2011; Jun;15(2): 213-7.
Moawad NS, Mahajan ST, Moniz MH, Taylor SE, Hurd WW. Current diagnosis and treatment of interstitial pregnancy. Am J Obstet Gynecol. 2010; Jan;202(1): 15-29.